| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ANIK | Common Stock | Options Exercise | $0 | +14.4K | +12.52% | $0.00 | 130K | Mar 11, 2024 | Direct | F1, F2 |
| transaction | ANIK | Common Stock | Tax liability | -$177K | -6.97K | -5.38% | $25.42 | 123K | Mar 11, 2024 | Direct | F3, F4 |
| transaction | ANIK | Common Stock | Options Exercise | $0 | +20K | +16.31% | $0.00 | 143K | Mar 11, 2024 | Direct | F5 |
| transaction | ANIK | Common Stock | Tax liability | -$165K | -6.47K | -4.54% | $25.42 | 136K | Mar 11, 2024 | Direct | F4, F6 |
| transaction | ANIK | Common Stock | Options Exercise | $0 | +30.1K | +22.07% | $0.00 | 166K | Mar 11, 2024 | Direct | F7 |
| transaction | ANIK | Common Stock | Tax liability | -$375K | -14.5K | -8.74% | $25.79 | 152K | Mar 11, 2024 | Direct | F8, F9 |
| holding | ANIK | Common Stock | 11.7K | Mar 11, 2024 | Revocable Trust | F10 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ANIK | Restricted Stock Unit | Options Exercise | $0 | -14.4K | -100% | $0.00 | 0 | Mar 11, 2024 | Common Stock | 14.4K | $0.00 | Direct | F11 |
| transaction | ANIK | Restricted Stock Unit | Options Exercise | $0 | -20K | -33.33% | $0.00 | 40K | Mar 11, 2024 | Common Stock | 20K | $0.00 | Direct | F12 |
| transaction | ANIK | Restricted Stock Unit | Options Exercise | $0 | -30.1K | -50% | $0.00 | 30.1K | Mar 11, 2024 | Common Stock | 30.1K | $0.00 | Direct | F13 |
| Id | Content |
|---|---|
| F1 | Reflects the third and final vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021. |
| F2 | Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 152 shares purchased on May 12, 2023 and 787 shares purchased on November 14, 2023. |
| F3 | Reflects an aggregate of 6,973 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024. |
| F4 | Reflects the closing price of ANIK common stock on March 8, 2024, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations. |
| F5 | Reflects the first vesting installment of RSUs granted on March 9, 2023. |
| F6 | Reflects an aggregate of 6,473 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024. |
| F7 | Reflects the second vesting installment of RSUs granted on March 11, 2022. |
| F8 | Reflects an aggregate of 14,534 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 11, 2024. |
| F9 | Reflects the closing price of ANIK common stock on March 11, 2024, the trading day on which the vesting of RSUs gave rise to tax withholding obligations. |
| F10 | Consists of shares transferred by Dr. Blanchard to The Cheryl R. Blanchard Amended and Restated Revocable Trust dated December 19, 2014, of which Dr. Blanchard is a beneficiary and the sole trustee. |
| F11 | Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022. |
| F12 | Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024. |
| F13 | Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023. |